BioCentury
ARTICLE | Clinical News

Inovio preclinical data

February 14, 2011 8:00 AM UTC

In mice, Inovio's SynCon DNA prostate cancer vaccine delivered with the company's electroporation system induced strong prostate specific antigen (PSA) and prostate-specific membrane antigen ( PSMA)-...